Increased insulin dose requirement of long-acting insulin analogues in obese patients with type 2 diabetes

被引：10
作者：
Schmid, C. [2 ]
Krayenbuhl, P. [3 ]
Wiesli, P. [1 ]
机构：
[1] Kantonsspital, Med Klin, CH-8500 Frauenfeld, Switzerland
[2] Univ Zurich Hosp, Dept Internal Med, Div Endocrinol & Diabet, Zurich, Switzerland
[3] Univ Zurich Hosp, Dept Internal Med, Med Policlin, Zurich, Switzerland
来源：
DIABETOLOGIA | 2009年 / 52卷 / 12期
关键词：
Hyperinsulinaemia; Insulin dose requirement; Long-acting insulin analogues; Obesity; Type; 2; diabetes; TO-TARGET TRIAL; NPH INSULIN; THERAPY; GLARGINE; DETEMIR;
D O I：
10.1007/s00125-009-1534-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2668 / 2669
页数：2
相关论文
共 50 条
[21]   Risk of breast cancer in patients on long-acting insulin analogues in comparison with those on human insulin [J].
Kostev, K. .
DIABETOLOGIA, 2012, 55 (05) :1554-1555
[22]   Risk of breast cancer in patients on long-acting insulin analogues in comparison with those on human insulin [J].
K. Kostev .
Diabetologia, 2012, 55 :1554-1555
[23]   A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study [J].
Gordon, J. ;
Pockett, R. D. ;
Tetlow, A. P. ;
McEwan, P. ;
Home, P. D. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (12) :1609-1618
[24]   Tirzepatide Versus Long-Acting Insulin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis [J].
Abu-Alsaud, Mohamed A. ;
Ellebedy, Mohamed ;
Hammad, Noha ;
Lamie, Mina I. ;
El-Rawy, Ahmed F. .
JOURNAL OF DIABETOLOGY, 2025, 16 (03) :204-213
[25]   Comparative efficacy and safety of long-acting insulin analogs in patients with type 2 diabetes failing on oral therapy: Systemic review and meta-analyses [J].
Bi, Yan ;
Li, Xiubin ;
Yang, Daizhi ;
Hao, Yuantao ;
Liang, Hua ;
Zhu, Dalong ;
Weng, Jianping .
JOURNAL OF DIABETES INVESTIGATION, 2012, 3 (03) :283-293
[26]   Revisiting the efficacy of long-acting insulin analogues on adults with type 1 diabetes using mixed-treatment comparisons [J].
Conegero Sanches, Andreia Cristina ;
Correr, Cassyano Januario ;
Venson, Rafael ;
Pontarolo, Roberto .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 94 (03) :333-339
[27]   Steady-state pharmacokinetics and glucodynamics of the novel, long-acting basal insulin LY2605541 dosed once-daily in patients with type 2 diabetes mellitus [J].
Sinha, V. P. ;
Howey, D. C. ;
Choi, S. L. ;
Mace, K. F. ;
Heise, T. .
DIABETES OBESITY & METABOLISM, 2014, 16 (04) :344-350
[28]   Evaluation of the effectiveness of long-acting insulin analogs in patients with type 2 diabetes mellitus [J].
Duman, Tuba Taslamacioglu ;
Aktas, Gulali ;
Tel, Burcin Meryem Atak ;
Bilgin, Satilmis ;
Kahveci, Gizem ;
Kurtkulagi, Ozge .
JOURNAL OF PUBLIC HEALTH-HEIDELBERG, 2023, 31 (12) :2039-2044
[29]   Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long-acting insulin in Type 2 diabetes [J].
Parkner, T. ;
Laursen, T. ;
Vestergaard, E. T. ;
Hartvig, H. ;
Smedegaard, J. S. ;
Lauritzen, T. ;
Christiansen, J. S. .
DIABETIC MEDICINE, 2008, 25 (05) :585-591
[30]   Model predictive control for dose guidance in long acting insulin treatment of type 2 diabetes [J].
Aradottir, Tinna Bjork ;
Boiroux, Dimitri ;
Bengtsson, Henrik ;
Kildegaard, Jonas ;
Jensen, Morten Lind ;
Jorgensen, John Bagterp ;
Poulsen, Niels Kjolstad .
IFAC JOURNAL OF SYSTEMS AND CONTROL, 2019, 9
12345